Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Neuronal Ca2+ signalling at rest and during spontaneous neurotransmission.

Kavalali ET.

J Physiol. 2019 Feb 8. doi: 10.1113/JP276541. [Epub ahead of print]

PMID:
30735245
2.

Antibodies raised against aldehyde-fixed antigens improve sensitivity for postembedding electron microscopy.

Hussain S, Fredriksen I, Ringsevjen H, Kavalali ET, Davanger S.

J Neurosci Methods. 2019 Apr 1;317:1-10. doi: 10.1016/j.jneumeth.2019.01.015. Epub 2019 Jan 28.

PMID:
30703389
3.

Time course and temperature dependence of synaptic vesicle endocytosis.

Chanaday NL, Kavalali ET.

FEBS Lett. 2018 Nov;592(21):3606-3614. doi: 10.1002/1873-3468.13268. Epub 2018 Oct 23. Review.

PMID:
30311950
4.

Behavioral Analysis of SNAP-25 and Synaptobrevin-2 Haploinsufficiency in Mice.

Monteggia LM, Lin PY, Adachi M, Kavalali ET.

Neuroscience. 2018 Aug 23. pii: S0306-4522(18)30559-1. doi: 10.1016/j.neuroscience.2018.08.014. [Epub ahead of print]

PMID:
30144509
5.

Genetic Dissection of Presynaptic and Postsynaptic BDNF-TrkB Signaling in Synaptic Efficacy of CA3-CA1 Synapses.

Lin PY, Kavalali ET, Monteggia LM.

Cell Rep. 2018 Aug 7;24(6):1550-1561. doi: 10.1016/j.celrep.2018.07.020.

6.

Cell-Specific Loss of SNAP25 from Cortical Projection Neurons Allows Normal Development but Causes Subsequent Neurodegeneration.

Hoerder-Suabedissen A, Korrell KV, Hayashi S, Jeans A, Ramirez DMO, Grant E, Christian HC, Kavalali ET, Wilson MC, Molnár Z.

Cereb Cortex. 2019 May 1;29(5):2148-2159. doi: 10.1093/cercor/bhy127.

PMID:
29850799
7.

Copine-6 Binds to SNAREs and Selectively Suppresses Spontaneous Neurotransmission.

Liu P, Khvotchev M, Li YC, Chanaday NL, Kavalali ET.

J Neurosci. 2018 Jun 27;38(26):5888-5899. doi: 10.1523/JNEUROSCI.0461-18.2018. Epub 2018 May 25.

8.

Optical detection of three modes of endocytosis at hippocampal synapses.

Chanaday NL, Kavalali ET.

Elife. 2018 Apr 23;7. pii: e36097. doi: 10.7554/eLife.36097.

9.

Presynaptic origins of distinct modes of neurotransmitter release.

Chanaday NL, Kavalali ET.

Curr Opin Neurobiol. 2018 Aug;51:119-126. doi: 10.1016/j.conb.2018.03.005. Epub 2018 Mar 26. Review.

10.

Pin1 mediates Aβ42-induced dendritic spine loss.

Stallings NR, O'Neal MA, Hu J, Kavalali ET, Bezprozvanny I, Malter JS.

Sci Signal. 2018 Mar 20;11(522). pii: eaap8734. doi: 10.1126/scisignal.aap8734.

11.

Spontaneous neurotransmission: A form of neural communication comes of age.

Kavalali ET.

J Neurosci Res. 2018 Mar;96(3):331-334. doi: 10.1002/jnr.24207. Epub 2017 Dec 8. No abstract available.

12.

The Ketamine Metabolite 2R,6R-Hydroxynorketamine Blocks NMDA Receptors and Impacts Downstream Signaling Linked to Antidepressant Effects.

Kavalali ET, Monteggia LM.

Neuropsychopharmacology. 2018 Jan;43(1):221-222. doi: 10.1038/npp.2017.210. No abstract available.

13.

How do you recognize and reconstitute a synaptic vesicle after fusion?

Chanaday NL, Kavalali ET.

F1000Res. 2017 Sep 22;6:1734. doi: 10.12688/f1000research.12072.1. eCollection 2017. Review.

14.

Sphingomimetic multiple sclerosis drug FTY720 activates vesicular synaptobrevin and augments neuroendocrine secretion.

Darios FD, Jorgacevski J, Flašker A, Zorec R, García-Martinez V, Villanueva J, Gutiérrez LM, Leese C, Bal M, Nosyreva E, Kavalali ET, Davletov B.

Sci Rep. 2017 Jul 20;7(1):5958. doi: 10.1038/s41598-017-05948-z.

15.

Effects of a ketamine metabolite on synaptic NMDAR function.

Suzuki K, Nosyreva E, Hunt KW, Kavalali ET, Monteggia LM.

Nature. 2017 Jun 21;546(7659):E1-E3. doi: 10.1038/nature22084. No abstract available.

PMID:
28640258
16.

Chronic lithium treatment elicits its antimanic effects via BDNF-TrkB dependent synaptic downscaling.

Gideons ES, Lin PY, Mahgoub M, Kavalali ET, Monteggia LM.

Elife. 2017 Jun 16;6. pii: e25480. doi: 10.7554/eLife.25480.

17.

Loss of Doc2-Dependent Spontaneous Neurotransmission Augments Glutamatergic Synaptic Strength.

Ramirez DMO, Crawford DC, Chanaday NL, Trauterman B, Monteggia LM, Kavalali ET.

J Neurosci. 2017 Jun 28;37(26):6224-6230. doi: 10.1523/JNEUROSCI.0418-17.2017. Epub 2017 May 24.

18.

Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets.

Li YC, Kavalali ET.

Pharmacol Rev. 2017 Apr;69(2):141-160. doi: 10.1124/pr.116.013342. Review.

19.

Selective molecular impairment of spontaneous neurotransmission modulates synaptic efficacy.

Crawford DC, Ramirez DM, Trauterman B, Monteggia LM, Kavalali ET.

Nat Commun. 2017 Feb 10;8:14436. doi: 10.1038/ncomms14436.

20.

An Intrinsic Transcriptional Program Underlying Synaptic Scaling during Activity Suppression.

Schaukowitch K, Reese AL, Kim SK, Kilaru G, Joo JY, Kavalali ET, Kim TK.

Cell Rep. 2017 Feb 7;18(6):1512-1526. doi: 10.1016/j.celrep.2017.01.033.

21.

Synaptotagmin-1- and Synaptotagmin-7-Dependent Fusion Mechanisms Target Synaptic Vesicles to Kinetically Distinct Endocytic Pathways.

Li YC, Chanaday NL, Xu W, Kavalali ET.

Neuron. 2017 Feb 8;93(3):616-631.e3. doi: 10.1016/j.neuron.2016.12.010. Epub 2017 Jan 19.

22.

CRISPR/Cas9 system-mediated impairment of synaptobrevin/VAMP function in postmitotic hippocampal neurons.

Horvath PM, Kavalali ET, Monteggia LM.

J Neurosci Methods. 2017 Feb 15;278:57-64. doi: 10.1016/j.jneumeth.2016.12.015. Epub 2016 Dec 23.

23.

Single synapse evaluation of the postsynaptic NMDA receptors targeted by evoked and spontaneous neurotransmission.

Reese AL, Kavalali ET.

Elife. 2016 Nov 24;5. pii: e21170. doi: 10.7554/eLife.21170.

24.

MeCP2 and histone deacetylases 1 and 2 in dorsal striatum collectively suppress repetitive behaviors.

Mahgoub M, Adachi M, Suzuki K, Liu X, Kavalali ET, Chahrour MH, Monteggia LM.

Nat Neurosci. 2016 Nov;19(11):1506-1512. doi: 10.1038/nn.4395. Epub 2016 Sep 26.

25.

Synaptic vesicle pool-specific modification of neurotransmitter release by intravesicular free radical generation.

Afuwape OA, Wasser CR, Schikorski T, Kavalali ET.

J Physiol. 2017 Feb 15;595(4):1223-1238. doi: 10.1113/JP273115. Epub 2016 Dec 2.

26.

Imaging Synaptic Vesicle Exocytosis-Endocytosis with pH-Sensitive Fluorescent Proteins.

Afuwape OA, Kavalali ET.

Methods Mol Biol. 2016;1474:187-200. doi: 10.1007/978-1-4939-6352-2_11.

PMID:
27515081
27.

A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle.

Nelson BR, Makarewich CA, Anderson DM, Winders BR, Troupes CD, Wu F, Reese AL, McAnally JR, Chen X, Kavalali ET, Cannon SC, Houser SR, Bassel-Duby R, Olson EN.

Science. 2016 Jan 15;351(6270):271-5. doi: 10.1126/science.aad4076.

28.

How Do RIM-BPs Link Voltage-Gated Ca(2+) Channels to Evoked Neurotransmitter Release?

Li YC, Kavalali ET.

Neuron. 2015 Sep 23;87(6):1119-1121. doi: 10.1016/j.neuron.2015.09.005.

29.

Ubiquitin-Synaptobrevin Fusion Protein Causes Degeneration of Presynaptic Motor Terminals in Mice.

Liu Y, Li H, Sugiura Y, Han W, Gallardo G, Khvotchev M, Zhang Y, Kavalali ET, Südhof TC, Lin W.

J Neurosci. 2015 Aug 19;35(33):11514-31. doi: 10.1523/JNEUROSCI.5288-14.2015.

30.
31.

Ca2+ Dependence of Synaptic Vesicle Endocytosis.

Leitz J, Kavalali ET.

Neuroscientist. 2016 Oct;22(5):464-76. doi: 10.1177/1073858415588265. Epub 2015 May 21. Review.

PMID:
25998187
32.

Molecular underpinnings of synaptic vesicle pool heterogeneity.

Crawford DC, Kavalali ET.

Traffic. 2015 Apr;16(4):338-64. doi: 10.1111/tra.12262. Review.

33.

The mechanisms and functions of spontaneous neurotransmitter release.

Kavalali ET.

Nat Rev Neurosci. 2015 Jan;16(1):5-16. doi: 10.1038/nrn3875. Review.

PMID:
25524119
34.

Age dependence of the rapid antidepressant and synaptic effects of acute NMDA receptor blockade.

Nosyreva E, Autry AE, Kavalali ET, Monteggia LM.

Front Mol Neurosci. 2014 Dec 1;7:94. doi: 10.3389/fnmol.2014.00094. eCollection 2014.

35.

How does ketamine elicit a rapid antidepressant response?

Kavalali ET, Monteggia LM.

Curr Opin Pharmacol. 2015 Feb;20:35-9. doi: 10.1016/j.coph.2014.11.005. Epub 2014 Nov 25. Review.

36.

Fast retrieval and autonomous regulation of single spontaneously recycling synaptic vesicles.

Leitz J, Kavalali ET.

Elife. 2014 Nov 21;3:e03658. doi: 10.7554/eLife.03658.

37.

Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses.

Gideons ES, Kavalali ET, Monteggia LM.

Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8649-54. doi: 10.1073/pnas.1323920111. Epub 2014 May 27.

38.

Visualizing presynaptic function.

Kavalali ET, Jorgensen EM.

Nat Neurosci. 2014 Jan;17(1):10-6. doi: 10.1038/nn.3578. Epub 2013 Dec 26. Review.

PMID:
24369372
39.

Reelin mobilizes a VAMP7-dependent synaptic vesicle pool and selectively augments spontaneous neurotransmission.

Bal M, Leitz J, Reese AL, Ramirez DM, Durakoglugil M, Herz J, Monteggia LM, Kavalali ET.

Neuron. 2013 Nov 20;80(4):934-46. doi: 10.1016/j.neuron.2013.08.024. Epub 2013 Nov 7.

40.

Scopolamine and ketamine: evidence of convergence?

Monteggia LM, Kavalali ET.

Biol Psychiatry. 2013 Nov 15;74(10):712-3. doi: 10.1016/j.biopsych.2013.08.011. No abstract available.

PMID:
24144324
41.

Acute suppression of spontaneous neurotransmission drives synaptic potentiation.

Nosyreva E, Szabla K, Autry AE, Ryazanov AG, Monteggia LM, Kavalali ET.

J Neurosci. 2013 Apr 17;33(16):6990-7002. doi: 10.1523/JNEUROSCI.4998-12.2013.

42.

Synaptic mechanisms underlying rapid antidepressant action of ketamine.

Kavalali ET, Monteggia LM.

Am J Psychiatry. 2012 Nov;169(11):1150-6. Review.

PMID:
23534055
43.

Circadian rhythms: Depression brought to light.

Monteggia LM, Kavalali ET.

Nature. 2012 Nov 22;491(7425):537-8. doi: 10.1038/nature11752. Epub 2012 Nov 14. No abstract available.

PMID:
23151474
44.

The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine.

Monteggia LM, Gideons E, Kavalali ET.

Biol Psychiatry. 2013 Jun 15;73(12):1199-203. doi: 10.1016/j.biopsych.2012.09.006. Epub 2012 Oct 11. Review.

45.

An essential role for histone deacetylase 4 in synaptic plasticity and memory formation.

Kim MS, Akhtar MW, Adachi M, Mahgoub M, Bassel-Duby R, Kavalali ET, Olson EN, Monteggia LM.

J Neurosci. 2012 Aug 8;32(32):10879-86. doi: 10.1523/JNEUROSCI.2089-12.2012.

46.

The impact of MeCP2 loss- or gain-of-function on synaptic plasticity.

Na ES, Nelson ED, Kavalali ET, Monteggia LM.

Neuropsychopharmacology. 2013 Jan;38(1):212-9. doi: 10.1038/npp.2012.116. Epub 2012 Jul 11. Review.

47.

The role of non-canonical SNAREs in synaptic vesicle recycling.

Ramirez DM, Kavalali ET.

Cell Logist. 2012 Jan 1;2(1):20-27.

48.

In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival.

Akhtar MW, Kim MS, Adachi M, Morris MJ, Qi X, Richardson JA, Bassel-Duby R, Olson EN, Kavalali ET, Monteggia LM.

PLoS One. 2012;7(4):e34863. doi: 10.1371/journal.pone.0034863. Epub 2012 Apr 9.

49.

VAMP4 directs synaptic vesicles to a pool that selectively maintains asynchronous neurotransmission.

Raingo J, Khvotchev M, Liu P, Darios F, Li YC, Ramirez DM, Adachi M, Lemieux P, Toth K, Davletov B, Kavalali ET.

Nat Neurosci. 2012 Mar 11;15(5):738-45. doi: 10.1038/nn.3067.

50.

A mouse model for MeCP2 duplication syndrome: MeCP2 overexpression impairs learning and memory and synaptic transmission.

Na ES, Nelson ED, Adachi M, Autry AE, Mahgoub MA, Kavalali ET, Monteggia LM.

J Neurosci. 2012 Feb 29;32(9):3109-17. doi: 10.1523/JNEUROSCI.6000-11.2012.

Supplemental Content

Loading ...
Support Center